USX:MGEN - Viridian Therapeutics, Inc Viridian Therapeutics, Inc
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance Note: This stock seems to be inactive



Signal Genetics, Inc. (MGEN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

30 Apr 2020 - Yahoo News
Signal Genetics, Inc. (MGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
usx:mgen

miRagen Therapeutics to Report First Quarter 2020 Financial Results On May 7, 2020

23 Apr 2020 - Yahoo News
BOULDER, Colo., April 23, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced it will report its first quarter 2020 financial results after the financial markets close ...
usx:mgen

Analysts Have Lowered Expectations For Miragen Therapeutics, Inc. After Its Latest Results

13 Mar 2020 - Yahoo News
Miragen Therapeutics, Inc. (NASDAQ:MGEN) just released its annual report and things are looking bullish. Results...
usx:mgen

Signal Genetics, Inc. (MGEN) Reports Q4 Loss, Lags Revenue Estimates

11 Mar 2020 - Yahoo News
Signal Genetics, Inc. (MGEN) delivered earnings and revenue surprises of -24.00% and -9.56%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
usx:mgen

miRagen Reports Fourth Quarter and Full Year 2019 Financial Results

11 Mar 2020 - Yahoo News
BOULDER, Colo., March 11, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), today reported operating highlights and financial results for the quarter and full-year ended December 31, 2019 and provided an outlook for 2020. This change from assessing overall response to skin response was ...
usx:mgen

Miragen Therapeutics, Inc. to Host Earnings Call

11 Mar 2020 - Yahoo News
NEW YORK, NY / ACCESSWIRE / March 11, 2020 / Miragen Therapeutics, Inc. (NASDAQ:MGEN) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 11, 2020 at ...
usx:mgen

Signal Genetics, Inc. (MGEN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

4 Mar 2020 - Yahoo News
Signal Genetics, Inc. (MGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
usx:mgen

miRagen Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results on March 11, 2020

20 Feb 2020 - Yahoo News
BOULDER, Colo., Feb. 20, 2020 -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted.
usx:mgen

Has Signal Genetics (MGEN) Outpaced Other Medical Stocks This Year?

14 Feb 2020 - Yahoo News
Is (MGEN) Outperforming Other Medical Stocks This Year?
usx:mgen

miRagen Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants to Purchase Common Stock

7 Feb 2020 - Yahoo News
BOULDER, Colo., Feb. 07, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock ...
usx:mgen

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T4

About · FAQs · StocksCafe © 2024 · Privacy · Terms